CAS: 2364554-48-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CK-274 REF: IN-DA01X12ACAS: 2364554-48-1 | 98% | To inquire | Wed 18 Dec 24 |
 | Aficamten REF: 4Z-A-409001CAS: 2364554-48-1 | - - - | To inquire | Fri 27 Dec 24 |
 | Aficamten REF: TM-T9258CAS: 2364554-48-1 | 98.99% - 99.19% | 72.00 €~2,182.00 € | Fri 27 Dec 24 |
 | Aficamten REF: TR-A347560CAS: 2364554-48-1 | - - - | 10,963.00 € | Tue 28 Jan 25 |
Ref: IN-DA01X12A
| 1mg | 199.00 € | ||
| 5mg | 470.00 € | ||
| 10mg | 519.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 18 Dec 2024
Ref: 4Z-A-409001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
Aficamten
CAS:2364554-48-1
Aficamten is a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy.
Formula:
C18H19N5O2
Purity:
98.99% - 99.19%
Color and Shape:
Solid
Molecular weight:
337.38
Ref: TM-T9258
| 1mg | 72.00 € | ||
| 5mg | 154.00 € | ||
| 10mg | 240.00 € | ||
| 25mg | 482.00 € | ||
| 50mg | 722.00 € | ||
| 100mg | 1,056.00 € | ||
| 1mL*10mM (DMSO) | 169.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Aficamten
Controlled ProductCAS:2364554-48-1
Formula:
C18H19N5O2
Color and Shape:
Neat
Molecular weight:
337.376
Ref: TR-A347560
| 500mg | 10,963.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
